A machine learning classifier using 33 host immune response mRNAs accurately distinguishes viral and non-viral acute respiratory illnesses in nasal swab samples.
Rushika PandyaYudong D HeTimothy E SweeneyYehudit Hasin-BrumshteinPurvesh KhatriPublished in: Genome medicine (2023)
This proof-of-concept signature has potential to be adapted as a clinical point-of-care test ('RespVerity') to improve the diagnosis of viral ARIs.